Diesse and AchilleS Vaccines working together for new monoclonal antibody based therapies
Siena, 19 February 2021 – Diesse Diagnostica Senese and AchilleS Vaccines today announced the signing of a strategic agreement under
AchilleS Vaccines Completes Industrial Development of Promising Treatment Against SARS-CoV-2
Innovative monoclonal antibody developed by AchilleS can be administered intramuscularly, broadening access to COVID-19 treatment; Industrial development of Monoclonal
Momentum for monoclonal antibodies in the fight against Covid-19
In Europe, the fight against the Covid-19 pandemic was mainly focused on developing a vast number of vaccines through the
Dalla Polio al Covi-19: Siena in prima linea contro le epidemie
Sabato 24 ottobre 2020, nella giornata mondiale della Polio, grazie al Rotary Club Montaperti con il patrocinio del Comune di
The Race to detect tomorrow’s diseases today
Thousands of viruses have the potential to leap from animals to humans Pietro Mastroeni, Chief Scientific Advisor at Achilles Vaccines and
Covid, la grande corsa alla cura con gli anticorpi. Le aziende in campo
A Siena la partnership tra laboratori e imprese ha un vantaggio competitivo: la formulazione più flessibile per un uso anche